Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schliemann

Showing results (291-300 of 427) with videos related to

Pageof 43
Sort By:
International Journal of Oncology|November 3, 2010
Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profileJohannes Dreischalück, Christian Schwöppe, Tilmann Spieker, et al.
Dermatologie (Heidelberg, Germany)|April 20, 2026
[Update on the assessment of the impact of occupational contact allergies in case of occupational skin disease no. 5101]Richard Brans, A Bauer, D Becker, et al.
Leukemia Research|August 7, 2007
Amsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysisT Kessler, M Mohr, C Müller-Tidow, et al.
BMJ Open|August 22, 2020
Impact of a mass media campaign on breast cancer symptoms awareness and screening uptake in Malaysia: findings from a quasi-experimental studyDésirée Schliemann, Mila Nu Nu Htay, Maznah Dahlui, et al.
Leukemia Research|May 3, 2015
Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculatureNiklas Börschel, Christian Schwöppe, Caroline Zerbst, et al.
Oncology Reports|September 6, 2007
Chemotherapy in metastatic malignant triton tumor: report on two casesN H Thoennissen, C Schliemann, U Brunnberg, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 28, 2018
Stromal collagen type VI associates with features of malignancy and predicts poor prognosis in salivary gland cancerLinus Angenendt, Jan-Henrik Mikesch, Dennis Görlich, et al.
Journal of Personalized Medicine|February 25, 2023
Management of Irreparable Posterosuperior Rotator Cuff Tears-A Current Concepts Review and Proposed Treatment Algorithm by the AGA Shoulder CommitteeJonas Pogorzelski, Marco-Christopher Rupp, Bastian Scheiderer, et al.
Transplantation and Cellular Therapy|June 26, 2025
High-Dose Melphalan Followed by Busulfan and Fludarabine Conditioning Prior to Allogeneic Stem Cell Transplantation in Elderly Patients with Active Acute Myeloid Leukemia-A Retrospective Single-Center StudyJulian Ronnacker, Marc-Andre Urbahn, Christian Reicherts, et al.
Haematologica|November 20, 2025
Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplicationSonia Jaramillo, Johannes Krisam, Lucian Le Cornet, et al.
Pageof 43

Showing results (291-300 of 427) with videos related to

Sort By:
Pageof 43
International Journal of Oncology|November 3, 2010
Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profileJohannes Dreischalück, Christian Schwöppe, Tilmann Spieker, et al.
Dermatologie (Heidelberg, Germany)|April 20, 2026
[Update on the assessment of the impact of occupational contact allergies in case of occupational skin disease no. 5101]Richard Brans, A Bauer, D Becker, et al.
Leukemia Research|August 7, 2007
Amsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysisT Kessler, M Mohr, C Müller-Tidow, et al.
BMJ Open|August 22, 2020
Impact of a mass media campaign on breast cancer symptoms awareness and screening uptake in Malaysia: findings from a quasi-experimental studyDésirée Schliemann, Mila Nu Nu Htay, Maznah Dahlui, et al.
Leukemia Research|May 3, 2015
Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculatureNiklas Börschel, Christian Schwöppe, Caroline Zerbst, et al.
Oncology Reports|September 6, 2007
Chemotherapy in metastatic malignant triton tumor: report on two casesN H Thoennissen, C Schliemann, U Brunnberg, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 28, 2018
Stromal collagen type VI associates with features of malignancy and predicts poor prognosis in salivary gland cancerLinus Angenendt, Jan-Henrik Mikesch, Dennis Görlich, et al.
Journal of Personalized Medicine|February 25, 2023
Management of Irreparable Posterosuperior Rotator Cuff Tears-A Current Concepts Review and Proposed Treatment Algorithm by the AGA Shoulder CommitteeJonas Pogorzelski, Marco-Christopher Rupp, Bastian Scheiderer, et al.
Transplantation and Cellular Therapy|June 26, 2025
High-Dose Melphalan Followed by Busulfan and Fludarabine Conditioning Prior to Allogeneic Stem Cell Transplantation in Elderly Patients with Active Acute Myeloid Leukemia-A Retrospective Single-Center StudyJulian Ronnacker, Marc-Andre Urbahn, Christian Reicherts, et al.
Haematologica|November 20, 2025
Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplicationSonia Jaramillo, Johannes Krisam, Lucian Le Cornet, et al.
Pageof 43